Mitoguazone

Chemical compound
  • L01XX16 (WHO)
Identifiers
  • (2E,2'E)-2,2'-(1E,2E)-propane-1,2-diylidenedihydrazinecarboximidamide
CAS Number
  • 459-86-9 checkY
PubChem CID
  • 5351154
ChemSpider
  • 4508218 ☒N
UNII
  • OD5Q0L447W
KEGG
  • D07258 checkY
ChEBI
  • CHEBI:43996 ☒N
CompTox Dashboard (EPA)
  • DTXSID70861943 Edit this at Wikidata
ECHA InfoCard100.121.515 Edit this at WikidataChemical and physical dataFormulaC5H12N8Molar mass184.207 g·mol−13D model (JSmol)
  • Interactive image
  • C\C(\C=N\NC(N)=N)=N/NC(N)=N
InChI
  • InChI=1S/C5H12N8/c1-3(11-13-5(8)9)2-10-12-4(6)7/h2H,1H3,(H4,6,7,12)(H4,8,9,13)/b10-2+,11-3+ ☒N
  • Key:PKDBCJSWQUOKDO-UHFFFAOYSA-M ☒N
 ☒NcheckY (what is this?)  (verify)

Mitoguazone (also known as methylglyoxal bis(guanylhydrazone) or MGBG) is a drug used in chemotherapy.[1]

References

  1. ^ Hoffmann H, Gutsche W, Amlacher R, Schulze W, Werner W, Lenk H, Wohlrab W, Haupt E (1989). "[Mitoguazone (methylglyoxal bis(guanylhydrazone))--its status and prospects]". Archiv für Geschwulstforschung (in German). 59 (2): 135–48. PMID 2655552.
  • v
  • t
  • e
Intracellular chemotherapeutic agents / antineoplastic agents (L01)
SPs/MIs
(M phase)
Block microtubule assembly
Block microtubule disassembly
DNA replication
inhibitor
DNA precursors/
antimetabolites
(S phase)
Folic acid
Purine
Pyrimidine
Deoxyribonucleotide
Topoisomerase inhibitors
(S phase)
I
II
II+Intercalation
Crosslinking of DNA
(CCNS)
Alkylating
Platinum-based
Nonclassical
Intercalation
Photosensitizers/PDTOther
Enzyme inhibitors
Receptor antagonists
Other/ungrouped


Stub icon

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e